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ABSTRACT 
This paper presents the solid phase transformation of carbamazepine-succinic co-
crystal. Solvent evaporation, slurry crystallization and cooling crystallization are the 
three techniques which represent the solution based method were used. In this study 
ethanol was used as solvent. CBZ-SUC co-crystals formations are studied by varying 
the mol ratio of CBZ and SUC. The CBZ-SUC co-crystals formation was characterized 
by using X-ray powder diffraction (XRPD), and optical microscopy. From the XRPD 
pattern profile, it shows that the co-crystals were formed for all the ratio of CBZ and 
SUC by the slurry crystallization and cooling crystallization. The results shows that the 
pattern profiles representing the co-crystal as no peak are develop with the raw material 
peak. The morphology of the co-crystals formation is needle-like co-crystals for cooling 
crystallization and solvent evaporation. The morphology of slurry crystallization is 
difficult to characterize due to agglomeration effects. Results from this research may be 
useful in pharmaceutical industry as the co-crystals are successfully formed.  
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ABSTRAK 
 
Kertas kerja ini menunjukkan penjelmaan fasa pepejal carbamazepine - succinic 
bersama kristal. Penyejatan pelarut, buburan penghabluran dan penyejukan 
penghabluran adalah tiga teknik yang digunakan. Dalam kajian ini etanol telah 
digunakan sebagai pelarut. Pembentukan CBZ - SUC bersama kristal dikaji dengan 
mengubah nisbah mol bagi CBZ dan SUC . Pembentukan CBZ - SUC bersama kristal 
dicirikan dengan menggunakan X -ray serbuk pembelauan (XRPD), dan mikroskop 
optik. Dari profil corak XRPD, ia menunjukkan bahawa kristal telah membentuk untuk 
semua nisbah CBZ dan SUC oleh penghabluran buburan dan penyejukan penghabluran. 
Keputusan menunjukkan bahawa profil corak mewakili kristal kerana tidak ada puncak 
yang wujud antara puncak bahan mentah. Morfologi pembentukan kristal adalah seperti 
jarum bersama kristal untuk penghabluran dan penyejatan pelarut penyejukan. 
Morfologi buburan penghabluran adalah sukar untuk dicirikan kerana kesan 
penumpuan. Hasil daripada kajian ini mungkin berguna dalam industri farmaseutikal 
kerana kristal berjaya dibentuk.  
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1 INTRODUCTION 
 
1.1 Background 
In the pharmaceutical industry, many life-saving drug compounds have to be disposed 
during the commercial production due to their low solubility. The successful 
development of new drugs has become the main challenges for the solubility 
improvement of poorly water soluble drug compounds (Qiao et al., 2012). Therefore, 
the improvement of the physicochemical properties of active pharmaceutical ingredients 
(APIs) has become an interest in the pharmaceutical industry. Many company in this 
industry has give the efforts and resources on the discovery of new crystalline forms of 
their APIs. 
 
Pharmaceutical co crystallization is technologies that provide a way for improving 
physicochemical and biopharmaceutical properties of APIs. This improvement of the 
properties of APIs is achieved through the development of a new class of crystalline 
solids, called pharmaceutical co crystals (Padrela et la., 2010). The pharmaceutical co 
crystal is done by the mixture of API and coformer like pharmaceutically acceptable 
molecule inside a crystal lattice. Therefore, co crystals increase the diversity of API 
form (Vitthalrao et al., 2013).  
 
Co crystals is the materials that are formed between a molecular or ionic API and a co 
crystal former that is a solid at room temperature, containing two or more discrete 
molecular entities in the crystal lattice (Almarsson et al., 2004). Co crystals are a 
multicomponent system in which two or more components crystallize into the same 
crystal lattice with distinctive physicochemical properties from the individual parent 
compounds. The formation of co-crystal occurs through hydrogen bond interactions 
between the drug and coformers. Acids and amides are widely used in research as 
coformers for CBZ co crystals due to their available hydrogen bonding sites (Weyna et 
al., 2009). 
  
The co crystals can be prepared by various methods. It consists of solid-based methods 
or solution-based methods. Solution based method consists of solvent evaporation, 
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cooling crystallization and slurry crystallization. Besides, solid based method involves 
of solid state grinding and hot melt extrusion. 
 
The co-crystal produced can be characterized by using powder X-ray diffraction 
(PXRD), single crystal X-ray diffraction (SXRD), Fourier transform infrared 
spectroscopy (FTIR), Raman spectroscopy, differential scanning calorimetry (DSC), 
solid state nuclear magnetic resonance spectroscopy (SSNMR), scanning electron 
microscopy (SEM), and terahertz spectroscopy. 
1.2 Motivation and statement of problem 
Drug molecules with limited aqueous solubility are the common issue in the research 
and development portfolios of discovery focused pharmaceutical companies (Blagden et 
al., 2007). Pharmaceutical development will be challenging as the issue of poor 
solubility of drug molecule may possibly cause to slow dissolution in biological fluids, 
insufficient and inconsistent systemic exposure and consequent lack efficacy in patients, 
particularly when delivered through the oral route of administration (Blagden et al., 
2007).  In the pharmaceutical industry, it is the poor biopharmaceutical properties rather 
than toxicity or lack of efficacy that are the main reasons why less than 1% of active 
pharmaceutical compounds sometime produce into the marketplace (Aakeroy et al., 
2009). Among these biopharmaceutical properties, solubility remains a key issue 
(Blagden et al., 2007), with drugs often damaged during commercial production due to 
their low solubility.  
Currently, one of the main challenges for the pharmaceutical industry is to improve the 
solubility of drug. The improvement of solubility and dissolution profiles of these drug 
molecules without changing the molecular structure is a special challenge for the 
successful development of pharmaceutical products (Thakuria et al., 2013). Since a long 
time ago, there is the interest in the design of pharmaceutical co crystals, which 
becomes as a potential method for improving the bioavailability of drugs with low 
aqueous solubility (Aakeroy et al., 2009). The improvements in the pharmaceutical 
sciences have provided several ways for solving the issues of low aqueous solubility 
(Blagden et al., 2007). Although some techniques are effective in order to improve the 
oral bioavailability, the successes of the ways are dependent at times on the specific 
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physicochemical nature of the molecules being studied. Therefore, a pharmaceutical co 
crystal can be designed with the aims to improve the solid-state properties of an API 
without influence its natural structure (Qiao et al., 2011).  A solution based method is 
carried out in order to determine the possibility of the formation of co-crystals from two 
components. 
1.3 Objective 
The following is the objective of this research: 
o To determine the stable region of carbamazepine-succinic (CBZ-SUC) co-
crystals formation using solution based method. 
1.4 Scope of this research 
The following are the scope of this research: 
i) Preparation of co-crystal by using solution based method which involve of 
solvent evaporation, slurry crystallization and cooling crystallization by 
using ethanol as a solvent.  
ii) Varied to a different mol ratio of CBZ and SUC in order to study the CBZ-
SUC co-crystal formation.  
iii) Characterizations and analysis of the physical characterization of the co-
crystal by using X-ray powder diffraction (XRPD), differential scanning 
calorimeter (DSC) and optical microscopy. 
 
1.5 Organisation of this thesis 
The structure of the reminder of the thesis is outlined as follow: 
Chapter 2 provides a literature review about the co-crystals based on the methods of co-
crystals formation. This chapter also provides the characterization of co-crystals 
techniques. All the relevant journal, technical paper and books are taken from those 
researchers will be studied and discussed in this chapter. 
Chapter 3 gives a review of the methods used in this study which consists of 
experimental methods and characterization methods.  More details and operating 
procedures are explained in this chapter. It also covered the material used in this study. 
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Chapter 4 covers on the results and discussion of the research from the experimental 
methods and characterization methods. All the experimental result and data is discussed 
in details which involves screening methods and characterization of co-crystal with 
different mol ratio. 
Chapter 5 draws together a summary of the thesis and outlines the future work with 
some of the recommendations that can be taken in conducting the research.  
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2 LITERATURE REVIEW 
 
2.1 Overview 
This paper presents on co-crystals, methods of co-crystals formation and 
characterization of co-crystals techniques.  
2.2 Introduction 
This study is about the co-crystals based on the methods of co-crystals formation which 
involves of solvent evaporation, slurry crystallization, cooling crystallization, solid state 
grinding and hot melt extrusion. The characterization of co-crystals techniques consists 
of differential scanning calorimetry (DSC), Fourier transform infrared spectroscopy 
(FTIR) and x-ray powder diffraction (XRPD).  
2.3 Co-crystals 
Pharmaceutical co-crystals have recently been suggested as good materials in drug 
discovery and development (Almarsson, 2004). A pharmaceutical co crystal is defines 
as a co crystal with one of the co crystal components as an Active Pharmaceutical 
Ingredient (API) and the other components are known as coformers. From the 
definition, it state that an API hydrate is not a co crystal, however a solid-state API 
hydrate can co crystallise with a solid coformer to form a co crystal (Chieng et al., 
2009). Co-crystals are self-assembled at the molecular scale and can significantly 
expand the number of crystal forms of a given API over polymorphs, solvates and salts 
(Almarsson, 2004).Co-crystals may also play a role in modifying the physical properties 
of an API, including stability, solubility and dissolution(Remenar, 2003). Several co-
crystals of carbamazepine have been reported (Fleischman, 2003). According to 
Aakeroy and Salmon (2005), the co crystal involves of two or more components of 
structurally homogeneous crystalline materials exists in exact stoichiometric amounts. It 
is important to note that a co crystal is a single phase of multiple components and not a 
mixture of single component crystalline phases (Seefeldt et al., 2006). Co crystals are 
multiple component crystals that often rely on hydrogen bonds between neutral 
molecules (Seefeldt et al., 2006). The co crystal components are different neutral 
molecular reactants which are solids at ambient temperature (Qiao et al, 2011). Co 
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crystals are an important class of pharmaceutical materials that can improve solubility 
and dissolution by forming a crystal of a drug and other favourable molecule or 
coformer with certain stoichiometric compositions (Thakuria et al., 2013). In order to 
control co crystals solubility several ways is provide by the wide range of conformer 
properties and interactions in the solid and solution phases. Co-crystals have different 
physical properties such as habit, bulk density, solubility, compressibility, friability, 
melting point, hygroscopy, and dissolution rate (Steed, 2013).Formation of a co-crystal 
is aimed to transform an amorphous or hard-to-crystallise API into a readily handled, 
stable crystalline solid (Steed, 2013). 
2.4 Methods of Co-crystal Formation 
There are a lot of methods that have been proposed for the preparation of co crystals due 
to the great interest in the area. The co crystal preparation methods consist of solid-
based methods or solution-based methods. The solid-state method involves a 
stoichiometric mixture of drug and coformer and, since stoichiometric or 
nonstoichiometric experiments can be carried out in solution, the solution-based 
methods are based on the saturation condition of the co crystal systems (Alhalaweh, 
2012). Solution based method includes solvent evaporation, cooling crystallization and 
slurry crystallization. While, solid based method involves of solid state grinding and hot 
melt extrusion. 
2.4.1 Solvent Evaporation 
Co crystallisation by evaporation of stoichiometric solutions is depends on the use of 
solvents or solvent mixtures where the co crystal is saturates and the components have 
same solubility (Qiao et al., 2011). Solvent evaporation consist super saturation of 
solution by evaporation, cooling and addition of solubility changing solvent or 
substance. Solvent evaporation involves of preparation of two or more suspensions by 
dissolution of stoichiometric amounts of materials in a solvent, mixing of suspensions 
and storage under suitable temperatures for co-crystallization (Vitthalrao et al., 2013). 
2.4.2 Cooling Crystallization 
Cooling crystallisation is the method of varying the temperature of the crystallisation 
system, which has a great interest for its potential of a large scale of co crystal 
production. First, large amounts of reactants and solvent are mixed in a reactor typically 
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a jacketed vessel, and then the system is heated to a higher temperature to make sure all 
solutes are totally dissolved in the solvent and is followed by a cooling down step (Qiao 
et al., 2011). Co crystals will precipitate when solution becomes supersaturated with 
respect to co crystal as the temperature drops down (McNamara et al., 2006). 
2.4.3 Slurry Crystallization 
Slurry crystallization is the method that involves the addition of crystallization solvent 
in the components like API along with its acceptable former. The selection of this 
method is based on the physical stability of the crystallization solution to co crystals and 
its solid former. The study on synthesis of co crystals through slurry crystallization was 
done in sixteen co crystal system with optimum result (Vishwashwar et al., 
2006).Preparation of co crystals for Trimethoprim and sulfamethoxazole through slurry 
technique used simple distilled water as solvent and while, co crystals of aspirin is 
designed with 4, 4-Dipyridil as a conformer is done by using slurry crystallization 
method (Mundhe et al., 2013).  
2.4.4 Solid State Grinding 
Solid state grinding is an alternative method for solution based co crystallization 
process. Particle size reduction is done in mixture which increases the covalent 
reactivity. This method has increase in selectivity and simplicity over solution 
crystallization technique. The application of solid state grinding was studied using six 
co crystals of sulfadimidine with anthranillic acid and salicylic acid, the co-crystal of 
sulfadimidine –salicylic acid while grinding with anthranillic acid (Mundhe et al., 
2013). The replacement of Salicylic acid with anthranillic acid occurs because of usual 
pattern of hydrogen bonding of both of co crystals (Trask et al., 2005). The hydration of 
caffeine is reported but the study of preparation by solid grinding in a ball mill is also 
proved (Trask et al., 2005). The hydrogen bonding preferences was showed in number 
of fact for modification in solid grinding method (Kurod et al., 2002). The solid 
grinding produced co crystals which were not possible by solution evaporation. This 
method was used for formation of co crystal phase with several coloristic properties 
(Jones et al., 20050. The solid grinding approach is having problem of polymorphic 
transition during the process which causes in dangerous side effect. 
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2.4.5 Hot Melt Extrusion 
Extrusion is one of the methods for synthesis of cocrystals which involves highly 
efficient mixing, improved surface contacts and solvent is not use in the co crystals 
preparation (Mundhe et al., 2013). The selection of this method is based on 
thermodynamic stability of compound. This method was studied with the use of four 
models for cocrystal formation (Dhumal et al., 2010). Solvent drop extrusion technique 
used to optimize and make the process more flexible. Solvent drop extrusion technique 
gives an advantage to do the process at lower temperature. Hot melt extrusion method 
was used in synthesis of Carbamazepine-nicotinamide cocrystals with polymer as 
former (Ruecroft, 2005). Continuous cocrystallization, API and coformer poured in the 
twin extruder and thus the barrel temperature also increases. 
2.5 Characterization of Co-crystals Techniques 
The co-crystal characterization is involves structural assessment and properties 
evaluation. There are several analytical techniques which are used for characterization 
of crystal structures and properties evaluation. The basic physicochemical properties of 
co crystal can usually be characterised by powder X-ray diffraction (PXRD), Fourier 
transform infrared spectroscopy (FTIR) and differential scanning calorimetry (DSC).  
2.5.1 Differential Scanning Calorimetry 
DSC is the most widely used technique for the thermal property testing of co crystals. It 
is the chosen technique for obtaining comprehensive melting point data and additional 
thermal data, like the enthalpy of melting, can also be determined simultaneously. 
Besides to being a characterisation technique, DSC has recently been used as a 
screening tool for rapid co crystal screening (Lu et al., 2008; Mohammad et al., 2011). 
From Figure 2.1, it shows the DSC thermograms of pure components and the co crystals 
prepared by various methods. It can be observed that all the components have a single 
melting point with endothermic peaks. The heat of fusion and the onset temperature also 
could be obtained. 
 
 9 
 
 Figure  2-1: DSC thermograms of CBZ, NCT, and cocrystals (Sources: Seefeldt 
et al., 2006) 
2.5.2 Fourier Transform Infrared Spectroscopy 
Fourier Transform Infrared Spectroscopy (FTIR) is used to detect possible co 
crystallization. It is widely used for spectroscopic technique in determining the chemical 
conformation compounds. From the Figure 2.2, the co crystals prepared by the solution 
cooling crystallization method showed changes in the peak positions of carbonyl and 
amide groups, which suggested interactions between the CBZ and NCT and a new 
phase formation (Rahman et al., 2011).The co crystals prepared by the solvent 
evaporation and melting method also showed characteristic peaks of the co crystals at 
1,655, 1,681, 3,386, and 3,446 cm−1, which show hydrogen bond formation between 
CBZ and NCT. This showed the present of unreacted CBZ which had not transformed 
into the co crystals.  
2.5.3 X-Ray Powder Diffraction 
X-ray Powder Diffraction (XRPD) is one of the primary techniques used to examine the 
physico-chemical properties of co crystals. XRPD gives a unique ‘fingerprint’ 
diffraction pattern characteristic of a particular solid form and does not need the growth 
of high-quality single crystals to obtain the data (Steed, 2013). From the XRPD, the new 
compound form and the possibility of co-crystals form for the compound can be easily 
seen based on the powder diffractogram. The diffractograms of the CBZ, NCT, and co 
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crystals are shown in Figure 2.3. The diffractogram of CBZ and its dehydrate forms 
showed sharp peaks at 2θ values. The diffractogram of NCT showed peaks at 2θ values. 
This showed the formation of a new crystalline phase.  
 
 
 
Figure  2-2:  FTIR spectra of CBZ, NCT, and cocrystals (Source: Rahman et al., 
2011) 
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Figure  2-3: PXRD diffractograms of CBZ, NCT, and cocrystals (Source: 
Rahman et al., 2011) 
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2.6      Summary 
In conclusion, the methods of co-crystals formation involves of solution based method 
and solid based method. Solution based method includes solvent evaporation, cooling 
crystallization and slurry crystallization while solid based method involves of solid state 
grinding and hot melt extrusion. Characterization of co-crystals techniques includes 
differential scanning calorimetry (DSC), Fourier transform infrared spectroscopy 
(FTIR) and x-ray powder diffraction (XRPD). 
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3 MATERIALS AND METHODS 
 
3.1 Overview 
This paper presents the experimental methods and characterization methods in order to 
study the solid phase transformation of carbamazepine-succinic co-crystal.  
3.2 Introduction 
This study is conducted by experimental of solution based method which involves three 
techniques of solvent evaporation, slurry crystallization and cooling crystallization by 
using ethanol as a solvent. Then, the experimental result is characterized by using x-ray 
powder diffraction (XRPD) and optical microscopy. The pure component is 
characterized by using differential scanning calorimetry (DSC) and x-ray powder 
diffraction (XRPD).  
3.3 Chemicals 
(Carbamazepine 99%), (Succinic 99%) and (Ethanol HPLC grade 99%) were obtained 
from Sigma-Aldrich Chemical Co while (Acetone 99%) was obtained from Fischer 
company. 
3.4 Experimental Methods  
In this study, the experimental method is conducted using solution based method via 
solvent evaporation, slurry crystallization and cooling crystallization. Ethanol was used 
as a solvent. The experimental method is taken from (Zakiriah, 2012). 
3.4.1 Preparation of Carbamazepine-Succinic Co-crystal 
Different mol ratio of carbamazepine and succinic is weighed as listed in Table 3-1. 
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Table  3-1: Experimental conditions used in the preparation of solutions 
 
Carbamazepine, 
CBZ Succinic, SUC 
Mol ratio 
(SUC/CBZ) 
Mass 
(g) 
Mol 
(mmol) 
Mass 
(g) 
Mol 
(mmol) 
0.167 0.71 0.042 0.355 0.5 
0.167 0.71 0.084 0.710 1.00 
0.167 0.71 0.105 0.886 1.25 
0.167 0.71 0.126 1.065 1.5 
0.167 0.71 0.147 1.243 1.75 
0.167 0.71 0.168 1.42 2.00 
0.167 0.71 0.189 1.589 2.25 
0.167 0.71 0.210 1.775 2.5 
0.167 0.71 0.231 1.953 2.75 
0.167 0.71 0.252 2.130 3.00 
 
3.4.2 Solvent Evaporation 
The solvent evaporation method was used to crystallize CBZ-SUC co-crystals. A 
mixture of 1:0.5 mol ratios of CBZ and SUC was dissolved in 35 ml of anhydrous 
ethanol in 100 ml conical flask and heated to 25°C in the orbital shaker. The solution 
was left at room temperature (~25°C). When all solutes are totally dissolved, parafilm is 
used to cover the conical flask and few holes is made on the parafilm. The resulting 
crystals were filtered and dried over filter paper (0.2µm). The procedures were repeated 
for different mol ratio SUC/CBZ as shown in Table 3.1. 
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3.4.3 Slurry Crystallization 
A stoichiometric mixture of 1:0.5 mol ratios of CBZ and SUC was slurried in 15 ml of 
anhydrous ethanol in a conical flask and stirred for 72 hours at room temperature in the 
orbital shaker. A filter paper (0.2µm) is used to filter the resulting solid and dried at 
room temperature. The procedures were repeated for different mol ratio SUC/CBZ as 
shown in Table 3.1. 
3.4.4 Cooling Crystallization 
A CBZ and SUC were added in 100 ml conical flask. The solids were dissolved in 15 
ml of anhydrous ethanol and heated to 60°C for 1h in the orbital shaker.  All the solutes 
were dissolved in the solvent and were followed by a cooling down step. Temperature 
was decreased in 5°C increments at 1h intervals to induce precipitation. The resulting 
solid form were filtered with a filter paper (0.2µm) and dried at room temperature. The 
procedures were repeated for different mol ratio SUC/CBZ as shown on Table 3.1. 
3.5 Characterization Analysis  
In this study, co-crystal characterization is conducted using optical microscopy and x-
ray powder diffraction (XRPD). The pure component is characterized by using 
differential scanning calorimetry (DSC) and x-ray powder diffraction (XRPD).The 
characterization analysis method is taken from (Abd Rahim, 2012). 
3.5.1 X-Ray Powder Diffraction (XRPD) 
XRPD is used to identify the sample obtained. Lines of pattern, generally known as 
powder pattern are the result from this measurement. To get a fine crystal powder, the 
sample used for measurement was ground using a mortar and pestle. A copper X-ray 
tube was used to generate the X-rays, which operated at 40 kV and 40mA. The plan 
used was from 3° to 40° for 2θ (angle). The step size and step time were 0.01 and 1 
second/step, respectively. 
3.5.2 Optical Microscopy 
Optical microscopy is used to see the shapes of the crystals obtained. The morphology 
of the co-crystals was characterized by using optical microscopy at a magnification of 
